iSpecimen Inc.
ISPC
$1.34
$0.075.51%
| Weiss Ratings | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.90 | |||
| Price History | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.94% | |||
| 30-Day Total Return | -32.66% | |||
| 60-Day Total Return | -59.02% | |||
| 90-Day Total Return | -69.12% | |||
| Year to Date Total Return | -51.62% | |||
| 1-Year Total Return | -81.74% | |||
| 2-Year Total Return | -94.72% | |||
| 3-Year Total Return | -98.30% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -88.64% | |||
| 52-Week Low % Change | 8.06% | |||
| Price | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.80 | |||
| 52-Week Low Price | $1.24 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Jul 11, 2024 | |||
| Valuation | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.29M | |||
| Enterprise Value | 726.45K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -18.99 | |||
| Earnings Per Share Growth | -16.21% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.09 | |||
| Price/Book (Q) | 0.24 | |||
| Enterprise Value/Revenue (TTM) | 0.07 | |||
| Price | $1.34 | |||
| Enterprise Value/EBITDA (TTM) | -0.08 | |||
| Enterprise Value/EBIT | -0.07 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 687.10K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 301 6700 | |||
| Address | 450 Bedford Street Lexington, MA 02420 | |||
| Website | ispecimen.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -93.91% | |||
| Profit Margin | -91.65% | |||
| Management Effectiveness | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -44.26% | |||
| Return on Equity | -- | |||
| Income Statement | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 10.39M | |||
| Total Revenue (TTM) | 10.39M | |||
| Revenue Per Share | $15.12 | |||
| Gross Profit (TTM) | 4.99M | |||
| EBITDA (TTM) | -9.50M | |||
| EBIT (TTM) | -9.76M | |||
| Net Income (TTM) | -9.52M | |||
| Net Income Avl. to Common (TTM) | -9.52M | |||
| Total Revenue Growth (Q YOY) | -4.17% | |||
| Earnings Growth (Q YOY) | 31.79% | |||
| EPS Diluted (TTM) | -18.99 | |||
| EPS Diluted Growth (Q YOY) | 55.01% | |||
| Balance Sheet | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.75M | |||
| Cash Per Share (Q) | $2.55 | |||
| Total Current Assets (Q) | 4.66M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.71M | |||
| Current Ratio (Q) | 0.743 | |||
| Book Value Per Share (Q) | $5.68 | |||
| Total Assets (Q) | 11.26M | |||
| Total Current Liabilities (Q) | 6.27M | |||
| Total Debt (Q) | 1.19M | |||
| Total Liabilities (Q) | 6.55M | |||
| Total Common Equity (Q) | 4.71M | |||
| Cash Flow | ISPC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.33M | |||
| Cash from Financing (TTM) | 2.05M | |||
| Net Change in Cash (TTM) | -969.70K | |||
| Levered Free Cash Flow (TTM) | -2.67M | |||
| Cash from Operations (TTM) | -4.35M | |||
